We are live on
!
Find out more
MG
Meditor Group Portfolio holdings
AUM
$48.1M
1-Year Est. Return
38.67%
This Fund
S&P 500
This Quarter
Est. Return
-16.31%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$359M
AUM Growth
-$86.9M
(-19%)
Cap. Flow
-$7.52M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelixis
EXEL
|
+$4.84M |
| 2 |
Alkermes
ALKS
|
+$2.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.17% |
Similar funds
BHCM
VMV
BHH
LAMC
MAM
BCM
LOF
CLCM
Meditor Group's Q4 2020 Portfolio in Review
As of Q4 2020, Meditor Group held 5 positions worth $359M, down 19% from $446M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2020: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 5-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 95% a quarter earlier.
- Meditor Group's biggest Q4 2020 reduction was Exelixis, cutting an estimated $4.84M.
- Meditor Group's ten largest holdings make up 100% of its $359M portfolio in Q4 2020.
- Meditor Group opened 0 new positions and closed 0 in Q4 2020.
- Meditor Group's portfolio value fell 19% quarter-over-quarter to $359M.
Based on Meditor Group's 13F filing for Q4 2020, filed 6 Jan 2021.